Printer Friendly
The Free Library
14,529,145 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse T cells topic

Subtopics (19)

 

Articles

1-100 out of 100 article(s)
Title Author Type Date Words
Gloucester Pharmaceuticals to Present Positive Results from Multiple Studies of ISTODAX[R] at the ASH Annual Meeting. Nov 24, 2009 540
Cytheris Announces Initiation of NCI/NIH-Sponsored Phase I/IIa Clinical Study of Tumor Vaccination and Interleukin-7 (IL-7) in Patients with High Risk Pediatric Solid Tumors. Nov 23, 2009 1136
Allos Therapeutics Announces New Data on FOLOTYN[TM] to be Presented at the American Society of Hematology Meeting. Nov 11, 2009 1054
Uni's immunity work gets pounds 3m shot in the arm. Oct 28, 2009 210
Eisai and TSD Japan Enter into a License and Joint Development Agreement of Denileukin Diftitox in Japan. Oct 26, 2009 746
Cytheris Announces Initiation of NIAID/NIH-Sponsored Phase I/IIa Clinical Trial of Interleukin-7 (IL-7). Oct 14, 2009 1687
Allos Therapeutics Announces U.S. Availability of FOLOTYN[TM] (pralatrexate injection) for Relapsed or Refractory Peripheral T-Cell Lymphoma. Oct 5, 2009 980
Inovio Biomedical Therapeutic Cervical Cancer Vaccine Demonstrates Safety and Immunogenicity in Clinical Trial. Oct 5, 2009 1627
Allos Therapeutics' FOLOTYN[TM] First and Only FDA-Approved Therapy for Relapsed or Refractory Peripheral T-cell Lymphoma. Sep 25, 2009 1884
Cytheris Announces Interim Data from INSPIRE Study Showing Interleukin-7 (CYT107) Induces Dose-Dependent and Sustained Increase of CD4 T Cells in Chronic HIV-Infected Patients. Sep 15, 2009 1163
Cytheris to Present Interim Data from INSPIRE HIV Multicenter Study in Oral Late Breaker at ICAAC. Sep 9, 2009 546
Opexa Reports Additional Favorable Data with Tovaxin[R] for Multiple Sclerosis. Clinical report Sep 8, 2009 1026
FDA Advisory Committee Recommends Gloucester Pharmaceuticals' Romidepsin for Approval for Cutaneous T-cell Lymphoma. Sep 2, 2009 592
Allos Therapeutics Announces FDA Advisory Committee Recommends Accelerated Approval of FOLOTYN[TM] (pralatrexate) for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma. Sep 2, 2009 1233
Selective IgA deficiency and common variable immunodeficiency/ IgA eksikligi ve yaygin degisken immun yetmezlik. Kamber, Kadri; Karali, Zuhal; Kilic, S. Sebnem Report Sep 1, 2009 3636
Gloucester Pharmaceuticals Completes $29 Million Financing. Aug 25, 2009 504
Gloucester Pharmaceuticals Announces FDA Advisory Committee Meeting to Discuss Romidepsin New Drug Application. Aug 17, 2009 335
Allos Therapeutics Announces FDA Advisory Committee to Review Pralatrexate for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma. Aug 10, 2009 472
YAUPON ENROLLS PHASE 2 OF CLEARAZIDE FOR T-CELL LYMPHOMA. Clinical report Aug 1, 2009 545
Zinc could help fight infections. Jul 31, 2009 263
Adamis Pharmaceuticals' Patented Vaccine Technology Induces Broad Immunity Against Influenza Virus. Jul 30, 2009 938
Allos Therapeutics Launches Peripheral T-Cell Lymphoma Website. Website overview Jul 23, 2009 676
Performance of ESAT-6 and CFP-10 in the diagnosis of tubercular infection. Quattrocchi, Manuela; Lobreglio, Giambattista; Errico, Pierangelo; Pasanisi, Giancarlo; De Donno, An Clinical report Jul 1, 2009 2637
Changes in the activated cytotoxic suppressor T-lymphocytes in elderly patients with mediterranean spotted fever. Gospodinova, Margarita D.; Nenova, Marina A.; Mileva, Sevda S. Report Jul 1, 2009 2906
China : Coal-to-oil project gets go-ahead. Jun 27, 2009 408
Genetic study links narcolepsy to autoimmunity: other risk factors probably serve as disease triggers. Saey, Tina Hesman Jun 6, 2009 523
Widely used diabetes drug may improve cancer therapies. Jun 4, 2009 381
Gloucester Pharmaceuticals Presents Positive Clinical Data for Romidepsin in CTCL and Further Preclinical Evidence of Synergism with Bortezomib at ASCO. Clinical report Jun 1, 2009 1159
Mechanisms of allergic inflammation/Allerjik inflamasyonun mekanizmalari. Akdis, Mubeccel Report Jun 1, 2009 4348
Allos Therapeutics Reports Updated Data from Pivotol Phase 2 PROPEL Study of Pralatrexate at 45th ASCO Annual Meeting. May 30, 2009 1689
Gloucester Pharmaceuticals to Present New Data from Two Studies on Romidepsin at ASCO. Clinical report May 28, 2009 598
Allos Therapeutics Announces FDA Accepts Pralatrexate NDA for Filing and Grants the Application Priority Review Status. May 26, 2009 1128
Cytheris Announces Publication of IL-7 Primate Study Showing Rapid and Massive T Cell Homing to the Gut. May 12, 2009 1558
MaxCyte to present on development of novel tumor-targeted enhanced potency T cell immunotherapy at the 15th Annual Meeting of the International Society of Cellular Therapy (ISCT). May 4, 2009 859
Juvaris BioTherapeutics' Vaccine Adjuvant, JVRS-100, Generates Superior T-Cell Mediated Immune Responses to Influenza in Clinical Trial. Apr 27, 2009 856
Opexa to Present Tovaxin[R] Data at the American Academy of Neurology 2009 Annual Meeting. Clinical report Apr 27, 2009 724
India: Award of Orissa Coal Block Advances Tata-Sasol CTL Project. Apr 25, 2009 97
Opexa Publication of Tovaxin[R] Clinical Data in Journal of Clinical Immunology. Clinical report Apr 24, 2009 1208
India: Sasol and Tata mull investment in 80000 bpd CTL plant in India. Apr 18, 2009 120
Mutations that hide HIV from immune system weaken its ability to replicate. Apr 13, 2009 324
Invitrogen Launches Next-Generation Cell Culture Solution for Immunology Research. Apr 13, 2009 910
Damping vaginal inflammation may help prevent HIV. Brief article Apr 1, 2009 240
Research and Markets: The Report Competitor Analysis: CD3 Antagonists Lists Company-Specific R&D Pipelines of CD3 Antagonists. Report Mar 26, 2009 538
Allos Therapeutics Submits New Drug Application for Pralatrexate for Patients with Relapsed or Refractory Peripheral T-cell Lymphoma. Mar 25, 2009 1730
Cytheris Announces Publication of IL-7 HIV Data in The Journal of Clinical Investigation. Mar 17, 2009 1775
Immune cells in rheumatoid arthritis patients have prematurely aged chromosomes. Mar 5, 2009 478
New discovery to make human vaccine against bird flu a reality. Mar 3, 2009 379
JPT LAUNCHES "PEPTRACK" FOR T-CELL ASSAYS IN VACINE DEVELOPMENT. Mar 1, 2009 378
Allos Therapeutics Announces Final Results from Pivotal PROPEL Trial of Pralatrexate in Patients with Peripheral T-cell Lymphoma. Feb 3, 2009 1912
Potential therapeutic target for autoimmune diseases identified. Jan 25, 2009 416
India : Tata, Jindal Steel pip RIL for $6-8 bn CTL project. Jan 21, 2009 287
India: Inter-ministerial group on CTL projects shortlists companies. Jan 21, 2009 471
India: Tata JV & JSPL win CTL project worth USD 6-8 bn. Jan 21, 2009 167
India: Tata JV, JSPL pip Reliance Industries for CTL project. Jan 21, 2009 145
CTL Introduces Innovative Touch Screen Convertible Netbook. Jan 9, 2009 627
Indonesia : Sasol of South Africa plans to build CTL plant in Indonesia. Jan 5, 2009 140
Immune cells implicated in Parkinson disease. Dec 23, 2008 225
Gloucester Pharmaceuticals Announces Positive Results from Phase 1/2 Multiple Myeloma Clinical Trial at ASH. Financial report Dec 9, 2008 1020
Gloucester Pharmaceuticals Announces Positive Results from Romidepsin T-cell Lymphoma Clinical Trials at ASH. Financial report Dec 8, 2008 1749
Two Pralatrexate Studies Presented at the 50th Annual Meeting of the American Society of Hematology. Dec 6, 2008 1414
South Africa: S.Africas IDC, Sasol CTL project to cost $12.5 bln. Dec 3, 2008 140
New therapeutic target for cancer identified. Dec 3, 2008 324
Immune activation and viraemia: reciprocal interactions in disease pathogenesis. Kelleher, Peter Clinical report Dec 1, 2008 2915
Gloucester Pharmaceuticals to Present Positive Results from Multiple Romidepsin Clinical Trials at the ASH Annual Meeting. Nov 20, 2008 686
Geron Scientists and Collaborators Demonstrate TAT2 - A Small Molecule Telomerase Activator - Enhances Antiviral Function of Immune Cells From HIV+ Donors. Nov 10, 2008 821
Opexa Provides Additional Promising Data Including Statistically Significant Reduction in Disability With Tovaxin(R) for the Treatment of Multiple Sclerosis. Oct 23, 2008 1854
Argos Therapeutics Publishes Approach to Generating High-Avidity Cytotoxic T Cells with Dendritic Cell-Based Immunotherapy. Oct 21, 2008 593
FDA Grants Full Approval to ONTAK' (denileukin diftitox) For Use in Patients with Cutaneous T-Cell Lymphoma (CTCL). Oct 16, 2008 539
VGX Pharmaceuticals Presents Non-Human Primate Study Data at AIDS Vaccine 2008 Conference. Conference news Oct 15, 2008 596
United States: Shenhua Ningxia Coal Group boosts CTL project with Sasol. Oct 15, 2008 170
Argos Therapeutics Publishes Approach to Improving Dendritic Cell-Based Immunotherapy. Oct 9, 2008 563
Angiogenic non-Hodgkin T/natural killer (NK)-cell lymphoma: report of three cases. Martins-Filho, Rubens A.; Demarco, Ricardo C.; Valera, Fabiana C.P.; Shaletich, Catarina; Felix, Pau Clinical report Oct 1, 2008 2130
United States: CTL Launches Two Sub-USD500 Net books. Sep 30, 2008 189
Top-Line Data from Opexa's Phase IIb Tovaxin(R) Study to be Presented at World Congress on Treatment and Research in Multiple Sclerosis. Sep 11, 2008 994
Altor BioScience Licenses T-cell Receptors Targeting HIV and Hepatitis C from Massachusetts General Hospital. Sep 10, 2008 394
India: GMR to enter CTL. Sep 8, 2008 300
Opexa Therapeutics and Myelin Repair Foundation Partner on Novel Multiple Sclerosis Research Program. Sep 3, 2008 1149
Effects of flaxseed lignan on in vitro mitogen-stimulated t cell proliferation. Rhee, Yeong; Brunt, Ardith Report Sep 1, 2008 2742
T cells get tough against HIV: in mice, RNA 'scissors' keep the AIDS virus at bay. Barry, Patrick Aug 30, 2008 380
India: Coal ministry disqualifies Rel Power s bid for CTL project. Aug 22, 2008 212
Argos Therapeutics and Universite de Montreal Present Novel Method to Create Personalized Immunotherapy Treatments that Stimulate HIV-Specific T Cells. Aug 5, 2008 787
Record View: Don't cell out on our jails. Aug 4, 2008 296
USA: Jay Lauds Plan to Build WVs First-Ever CTL Plant. Jul 30, 2008 176
India: Reliance, Tata among 22 firms in race for CTL project. Jul 28, 2008 237
YOU WON'T CELL US THIS; MSPs slam plans to slash jail numbers. Jul 2, 2008 310
Early Results from Ongoing Clinical Study of Hepatitis C Vaccine Delivered by Inovio Biomedical's Electroporation System Show Increased T-Cell Responses and Reduced Viral Loads. Jun 30, 2008 1010
Cytheris Announces Publication of IL-7 Oncology Data in The Journal of Experimental Medicine. Jun 26, 2008 904
India: Indian coal ministry invites applications for CTL projects. Jun 22, 2008 316
Opexa Therapeutics Reports Favorable Two-Year Data in Phase I/II Retreatment Studies of Tovaxin(R) for Multiple Sclerosis. Jun 12, 2008 1190
India: Big-ticket bids to hot up CTL project. Jun 12, 2008 187
China: China takes refuge in coal-fed process to secure oil. Jun 10, 2008 367
Canada: West Hawk Invited to Participate in Developing Lu'An's Xinjiang Coal Mine and Coal-to-Liquid Projects. Jun 6, 2008 452
China: China builds plant to turn coal into barrels of oil. Jun 6, 2008 1358
Gloucester Pharmaceuticals Announces Podium Presentation of Positive Results from Phase 2b Registration Trial of Romidepsin in Refractory CTCL. Financial report Jun 5, 2008 1061
Allos Therapeutics Announces Interim Data from Phase 1 Study of PDX in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma. Jun 5, 2008 1169
Botswana: Problems mount at giant coal mine/power/CTL plant project in Botswana. May 31, 2008 141
Botswana: Problems mount at giant coal mine/power/CTL plant project in Botswana. May 29, 2008 590
Stimulation of Interleukin-4 production in EL4 T cells via increased NF-at binding activity by Scapharca broughtonii. Kim, Tae Sung; Yoo, Jin Cheol Report Apr 1, 2008 2453
Loss of TAP and LMP Expression in Renal Cell Carcinomas: A Mechanism of Tumor Escape. Report Mar 1, 2001 3077
Role of MIP1a in Anti-Tumor Immunity and Therapy. Apr 1, 2000 1648

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles